LOGO-01.png
Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021
February 08, 2021 20:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
December 15, 2020 01:33 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
LOGO-01.png
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
December 04, 2020 06:34 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
December 01, 2020 18:47 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports Third Quarter 2020 Financial Results
November 20, 2020 06:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
November 15, 2020 20:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into a development and...
LOGO-01.png
Burning Rock to Present Validation Data of Magnis BR at the AMP Annual Meeting
October 29, 2020 23:21 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that analytical validation data of its fully-automated...
LOGO-01.png
Burning Rock Announces Preliminary Third Quarter 2020 Results and Schedules Earnings Release on November 20, 2020
October 20, 2020 21:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock to Present Data on Its Early Detection ELSA-seq at ESMO Asia Virtual Congress 2020
October 20, 2020 21:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that new data for its early detection ELSA-seq test...
LOGO-01.png
Burning Rock to Participate in Morgan Stanley 2020 Healthcare Conference
September 03, 2020 02:09 ET | Burning Rock Biotech Limited
SHANGHAI, China, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare...